IRIS Institutional Research Information System - OPENBS Open Archive UniBS

NIBBIO, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.147
AS - Asia 2.061
EU - Europa 1.462
SA - Sud America 521
Continente sconosciuto - Info sul continente non disponibili 88
AF - Africa 54
Totale 7.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.952
SG - Singapore 804
IT - Italia 622
CN - Cina 488
BR - Brasile 437
HK - Hong Kong 222
DE - Germania 196
VN - Vietnam 154
BD - Bangladesh 151
GB - Regno Unito 106
CA - Canada 99
FR - Francia 97
FI - Finlandia 94
RU - Federazione Russa 72
TR - Turchia 65
UA - Ucraina 46
IN - India 43
MX - Messico 35
CZ - Repubblica Ceca 33
PL - Polonia 31
NL - Olanda 30
AR - Argentina 24
AT - Austria 23
IE - Irlanda 21
SE - Svezia 21
ZA - Sudafrica 21
JP - Giappone 19
ID - Indonesia 18
IQ - Iraq 18
EC - Ecuador 14
PY - Paraguay 13
ES - Italia 12
TT - Trinidad e Tobago 12
CO - Colombia 10
CR - Costa Rica 10
PK - Pakistan 10
SA - Arabia Saudita 10
PT - Portogallo 9
AL - Albania 8
UZ - Uzbekistan 8
HN - Honduras 7
JM - Giamaica 7
LT - Lituania 7
MA - Marocco 7
VE - Venezuela 7
IL - Israele 6
NP - Nepal 6
SV - El Salvador 6
EG - Egitto 5
PE - Perù 5
PH - Filippine 5
PR - Porto Rico 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
BG - Bulgaria 4
ET - Etiopia 4
KG - Kirghizistan 4
PA - Panama 4
RO - Romania 4
AO - Angola 3
CL - Cile 3
DZ - Algeria 3
HU - Ungheria 3
KE - Kenya 3
KZ - Kazakistan 3
LV - Lettonia 3
NI - Nicaragua 3
NO - Norvegia 3
PS - Palestinian Territory 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CW - ???statistics.table.value.countryCode.CW??? 2
CY - Cipro 2
DK - Danimarca 2
GP - Guadalupe 2
GT - Guatemala 2
IR - Iran 2
JO - Giordania 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
EE - Estonia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
IM - Isola di Man 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 7.240
Salva come PNG Salva come JPEG
Città #
Ashburn 429
Singapore 412
San Jose 278
Hong Kong 222
New York 146
Council Bluffs 142
Beijing 115
Milan 112
Los Angeles 108
The Dalles 103
Munich 96
Brescia 73
Helsinki 70
Lauterbourg 60
Columbus 58
Fairfield 57
Boardman 55
Chandler 55
São Paulo 51
Ho Chi Minh City 50
Istanbul 49
Santa Clara 49
Chicago 43
Dallas 43
Princeton 37
Phoenix 35
Seattle 32
Hanoi 30
Moscow 30
Buffalo 29
Redondo Beach 29
Orem 28
San Francisco 28
Shanghai 28
Warsaw 28
Woodbridge 28
Houston 27
Cambridge 26
Rome 26
Frankfurt am Main 25
Jacksonville 25
Wilmington 24
Brno 23
London 22
Atlanta 21
Dublin 21
Montreal 20
Toronto 20
Denver 19
Romola 19
North Bergen 18
Turku 18
Brooklyn 17
Des Moines 16
Naples 16
Turin 16
Düsseldorf 15
Tokyo 15
Ann Arbor 14
Nuremberg 14
Palazzolo sull'Oglio 14
Stockholm 14
Amsterdam 13
Mexico City 13
Haiphong 11
Manchester 11
New Delhi 11
Belo Horizonte 10
Charlotte 10
Johannesburg 10
Porto Alegre 10
Ankara 9
Boston 9
Guangzhou 9
Newark 9
Olomouc 9
San José 9
Brasília 8
Changsha 8
Dearborn 8
Nanjing 8
Padua 8
Paris 8
Philadelphia 8
San Diego 8
Tashkent 8
Venice 8
Verona 8
Campinas 7
Jakarta 7
Las Vegas 7
Poplar 7
Rio de Janeiro 7
Vienna 7
Asunción 6
Bergamo 6
Chaguanas 6
Chennai 6
Curitiba 6
Guayaquil 6
Totale 4.062
Salva come PNG Salva come JPEG
Nome #
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 207
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials 195
Autistic symptoms predict social cognitive performance in patients with schizophrenia 178
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 169
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 166
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices 162
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review 157
Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial 146
Efficacy and tolerability of Brain Stimulation interventions in Borderline Personality Disorder: state of the art and future perspectives – A systematic review 145
Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting 139
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 137
Acceptability of cognitive remediation for schizophrenia: A systematic review and meta-analysis of randomized controlled trials 136
Psychological impact of Covid-19 pandemic in mental healthcare workers: a cross-sectional study in an Italian Department of Mental Health 132
The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study 132
Current Evidence and Theories in Understanding the Relationship between Cognition and Depression in Childhood and Adolescence: A Narrative Review 131
The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers 130
Autistic Symptoms and Social Cognition Predict Real-World Outcomes in Patients With Schizophrenia 126
Social Cognition in a Research Domain Criteria Perspective: A Bridge Between Schizophrenia and Autism Spectra Disorders 125
Effects of bilateral, bipolar-nonbalanced, frontal transcranial Direct Current Stimulation (tDCS) on negative symptoms and neurocognition in a sample of patients living with schizophrenia: Results of a randomized double-blind sham-controlled trial 124
Cognitive and clinical characteristics of offenders and non-offenders diagnosed with schizophrenia spectrum disorders: results of the Recoviwel observational study 124
Implementation of cognitive rehabilitation interventions for schizophrenia in low-income countries: An experience from Togo and Benin 122
Application of cognitive remediation in the world: new experiences from two schizophrenia rehabilitation centers in Togo and Benin 121
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 115
Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community 114
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 113
Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis 113
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 112
Autistic symptoms in people with schizophrenia: Neurocognitive, socio-cognitive, clinical and real-world functional characteristics of individuals without autistic features 111
The Relationship between Cognitive Impairment and Violent Behavior in People Living with Schizophrenia Spectrum Disorders: A Critical Review and Treatment Considerations 108
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 107
Personality traits and disorders among adult ADHD Patients: Is borderline personality disorder as common as we expect? 105
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 105
Verso la medicina di precisione in psichiatria: validazione clinica di un approccio farmacogenomico combinato nel trattamento del Disturbo Depressivo Maggiore 101
Assessment and correlates of autistic symptoms in Schizophrenia Spectrum Disorders measured with the PANSS Autism Severity Score: A systematic review 101
Schizophrenia during the COVID-19 pandemic 100
What impact can brain stimulation interventions have on borderline personality disorder? 99
Blood homocysteine concentration and mood disorders with mixed features among patients with alcohol use disorder 97
Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting 96
The interplay between childhood trauma, hopelessness, depressive symptoms, and mental pain in a large sample of patients with severe mental disorders: A network analysis 96
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia 95
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives 95
Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia 95
Shared and distinct abnormalities in sleep-wake patterns and their relationship with the negative symptoms of Schizophrenia Spectrum Disorder patients 93
Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review 91
Patient-reported outcomes in the clinical management of depression: current status and future directions 90
Does pharmacogenetic testing optimise antidepressant effectiveness in major depressive disorder? Data from a double blind randomized controlled trial in a real-world setting 89
Well-Being and Mental Health: Where Do We Stand After COVID-19 Pandemic? 89
Predictors of psychosocial functioning in people diagnosed with schizophrenia spectrum disorders that committed violent offences and in those that did not: Results of the Recoviwel study 87
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 86
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 83
Effectiveness and Safety of Bright Light Therapy in Oncological Patients: A Systematic Review 83
Paliperidone palmitate in short- and long-term treatment of schizophrenia 82
Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: A case-control study in the psychiatric wards of a Great Metropolitan Hospital in Milan 79
Non-pharmacological interventions to improve cognitive impairment and psychosocial functioning in schizophrenia: a critical review 78
Efficacy of Functional Remediation on Cognitive and Psychosocial Functioning in Patients with Bipolar Disorder: Study Protocol for a Randomized Controlled Study 78
Evidence-based psychosocial interventions in schizophrenia: A critical review 76
Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review 72
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 72
Gender Differences in Anxiety and Depression before and after Alcohol Detoxification: Anxiety and Depression as Gender-Related Predictors of Relapse 70
Editorial: Case reports in schizophrenia and psychotic disorders 67
Editorial: Case reports in Schizophrenia and psychotic disorders: 2023 62
Editorial: Methods and applications in psychopathology: new methods and trends for the understanding of neuropsychiatric disorders 60
Editorial: Cognitive and mental health improvement under- and post-COVID-19, volume III 59
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives 57
Treatment of Comorbid Adult Attention-deficit/Hyperactivity Disorder and Generalized Anxiety Disorder: 2 Case Reports 52
Editorial: Cognitive and mental health improvement under- and post-COVID-19 50
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 50
Mild motor signs in major depressive disorder: prevalence and clinical profile 45
Reply to: “Letter to the Editor: Cocaine use and cocaine use disorder - Revisiting epidemiology and clinical impact” 42
Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch 40
Cognitive Impairment Associated with Schizophrenia: insights and treatment perspectives 23
tDCS effects on life engagement in schizophrenia: results from a double-blind sham-controlled trial 18
Artificial intelligence applications in mental health: the state of the art 15
Artificial Intelligence in Schizophrenia Spectrum Disorders: Current Use and Future Perspectives. A Systematic Mapping Literature Review 13
Totale 7.333
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202297 0 0 0 7 5 6 4 10 7 15 6 37
2022/2023236 21 2 0 13 14 46 20 35 42 7 21 15
2023/2024559 21 15 50 41 32 87 25 12 71 28 4 173
2024/20251.424 26 29 39 165 147 110 129 70 193 134 216 166
2025/20263.469 338 396 252 528 343 229 410 163 203 273 212 122
2026/20271.219 197 169 204 649 0 0 0 0 0 0 0 0
Totale 7.333